Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer

PaperCitations, authors & open-access status

Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 214 citations, 2012 year and hybrid oa status.